Quercitrin Rapidly Alleviated Depression-Like Behaviors In Lipopolysaccharide-Treated Mice: The Involvement Of Pi3k/Akt/Nf-Kappa B Signaling Suppression And Creb/Bdnf Signaling Restoration In The Hippocampus

Quercitrin (Qc) is a well-known flavonoid compound that exerts anti-inflammation effects on various diseases. The present study aimed to investigate the antidepressant-like response of Qc and its underlying mechanisms concerning neuroinflammation and neuroplasticity in mice with lipopolysaccharide (LPS)-induced depression-like behaviors. The results showed a single dose of Qc (10 mg/kg) produced an antidepressant-like effect at 2 h postadministration and lasted for at least 3 days. The expressions of neuroplasticity signaling molecules of pCREB/BDNF/PSD95/Synapsin1 were upregulated at 2 h, and ERK signaling was upregulated for 3 days in the hippocampus after a single administration of Oc or ketamine. A 5-day treatment of LPS led to depression-like behaviors, including reduced sucrose preference and increased immobility in the tail suspension test or forced swim test, which were all reversed by a single dose of Qc. In LPStreated mice, Qc reduced the levels of inflammation-related factors including IL-10, IL-1 beta, and TNF-alpha in serum, as well as the activations of PI3K/AKT/NF-kappa B and MEK/ERK pathways in the hippocampus. Moreover, Qc restored the expressions of pCREB/ BDNF/PSD95/Synapsin1 signaling in the hippocampus that were impaired by LPS. LY294002, a PI3K inhibitor, but not PD98059, a MEK inhibitor, produced effects similar to Qc. LY294002 also restored the expressions of pCREB/BDNF/PSD95/Synapsin1 signaling in the hippocampus impaired by LPS. Additionally, subeffective doses of Qc and LY294002 induced behavioral and molecular synergism. Together, the depression-like behaviors in LPS-treated mice were alleviated by a single dose of Qc likely via inhibition of the activations PI3K/AKT/NF-kappa B inflammation signaling and subsequent improvement of neuroplasticity.